Interní Med. 2008; 10(9): 392-396

The treatment of chronic pulmonary hypertension

MUDr. Pavel Jansa1, prof. MUDr. Michael Aschermann DrSc2, prof. MUDr. Aleš Linhart CSc1
1 Centrum pro plicní hypertenzi, II. interní klinika kardiologie a angiologie, VFN a 1. LF UK, Praha
2 II. interní klinika kardiologie a angiologie 1. LF UK a VFN, Praha

Pulmonary hypertension is a heterogenous group of diseases characterized by increase of mean pulmonary arterial pressure. Clinical classification differentiates pulmonary arterial hypertension, pulmonary hypertension in cardiac diseases, pulmonary hypertension in respiratory diseases, chronic thromboembolic pulmonary hypertension and pulmonary hypertension from other causes. The goal of therapeutic intervention is to influence basic pathophysiological mechanisms (vasoconstriction, remodeling and thrombosis). The test of acute pulmonary vasodilatation is essential for decision about the pharmacological treatment. Only patients with a postive test are indicated for treatment with high doses of calcium channel blockers. This therapy with anticoagulation and treatment of heart failure is known as conventional. In case of a negative test besides chronic anticoagulation a specific therapy is indicated (prostanoids, endothelin receptor antagonists, phosphodiesterase 5 inhibitors). In case of exhaustion of pharmacological treatment options, an atrial septostomy and lung transplantation can be considered. Recently it has been shown that similar pharmacological strategies may be effective also in other forms of chronic pulmonary hypertension. In patients with chronic thromboembolic pulmonary hypertension a pulmonary artery endarterectomy is a potentially curable method. In case of exhaustion of all options in advanced cases a lung transplantation is indicated. Because of serious prognosis, sophisticated diagnostic and frequently a complicated therapy it is necessary to concentrate the care of patients with pulmonary hypertension to specialized centers.

Keywords: Key words: pulmonary hypertension, conventional therapy, specific pharmacotherapy, pulmonary artery endarterectomy.

Published: November 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jansa P, Aschermann M, Linhart A. The treatment of chronic pulmonary hypertension. Interní Med. 2008;10(9):392-396.
Download citation

References

  1. Barst RJ. Medical therapy for pulmonary hypertension. An overview of treatment and goals. Clin Chest Med 2001; 22: 509-515. Go to original source... Go to PubMed...
  2. Benza RL, Park MH, Keogh A, et al. Management of pulmonary arterial hypertension with a focus on combination therapies. J Heart Lung Transplant 2007; 26: 437-446. Go to original source... Go to PubMed...
  3. Bocchi EA, Guimaraes G, Mocelin A, et al. Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. Circulation, 2002; 106: 1097-1103. Go to original source... Go to PubMed...
  4. Bresser P, Pepke-Zaba J, Jais X, et al. Medical therapies for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006; 3: 594-600. Go to original source... Go to PubMed...
  5. Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 637-648. Go to original source... Go to PubMed...
  6. Doyle RL, McCrory D, Channick RN, et al. Surgical treatments/interventions for pulmonary arterial hypertension. Chest, 2004; 126: 63S-71S. Go to original source... Go to PubMed...
  7. Fuster V, Steele PM, Edwards WD, et al. Primary pulmonary hypertension and the importance of thrombosis. Circulation 1984; 70: 580-587. Go to original source... Go to PubMed...
  8. Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusing capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131: 650-656. Go to original source... Go to PubMed...
  9. Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary thromboendarterectomy. Experience and results in 1,500 cases. Ann Thorac Surg 2003; 76: 1457-1464. Go to original source... Go to PubMed...
  10. Lindner J, Jansa P, Kunstyr J, et al. Implementation of a new programme for the surgical treatment of CTEPH in the Czech Republic - pulmonary endarterectomy. Thorac Cardiov Surg 2006; 54: 528-531. Go to original source... Go to PubMed...
  11. Medical Research Council Working Party: Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet, 1981; i: 681-686. Go to original source...
  12. Schäfer H, Hasper E, Ewig S, et al. Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factors. Eur Respir J 1998; 12: 679-684. Go to original source... Go to PubMed...
  13. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol, 2004; 43: 5S-12S. Go to original source... Go to PubMed...
  14. Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111: 3105-2111. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.